Form 4: Elanco Animal Health CEO Receives Stock Grant
Insider Transaction (Form 4)
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 115 shares of common stock on September 4, 2026.
Summary
- Grant/award: acquired 115 Deferred Stock Units at $24.50 ($2,827) on September 4, 2026; holds 25,246 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffrey N Simmons — Director, Officer (PRESIDENT, CEO AND DIRECTOR)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Grant/award | Deferred Stock Units | 115.385 | $25 | $2.8K | 25,245.509 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Grant/award (115 shares) |
Keywords
insider transaction, Form 4, ELAN, Elanco Animal Health Inc, neutral, Jeffrey N Simmons
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.